These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25474159)

  • 21. [Recent advances on liver X receptors].
    Wang Q; Jiang Y
    Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):147-50. PubMed ID: 19558144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.
    Castrillo A; Tontonoz P
    Annu Rev Cell Dev Biol; 2004; 20():455-80. PubMed ID: 15473848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome.
    Vacca M; Degirolamo C; Mariani-Costantini R; Palasciano G; Moschetta A
    Wiley Interdiscip Rev Syst Biol Med; 2011; 3(5):562-87. PubMed ID: 21755605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear receptors as drug targets for metabolic disease.
    Schulman IG
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1307-15. PubMed ID: 20655343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol and male fertility: what about orphans and adopted?
    Maqdasy S; Baptissart M; Vega A; Baron S; Lobaccaro JM; Volle DH
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):30-46. PubMed ID: 22766106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
    Rigamonti E; Chinetti-Gbaguidi G; Staels B
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1050-9. PubMed ID: 18323516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic switching of human skeletal muscle cells in vitro.
    Thoresen GH; Hessvik NP; Bakke SS; Aas V; Rustan AC
    Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):227-34. PubMed ID: 21549583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors.
    Kang J; Rivest S
    Endocr Rev; 2012 Oct; 33(5):715-46. PubMed ID: 22766509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.
    Kiss M; Czimmerer Z; Nagy L
    J Allergy Clin Immunol; 2013 Aug; 132(2):264-86. PubMed ID: 23905916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPAR control: it's SIRTainly as easy as PGC.
    Sugden MC; Caton PW; Holness MJ
    J Endocrinol; 2010 Feb; 204(2):93-104. PubMed ID: 19770177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors.
    Tontonoz P
    Cold Spring Harb Symp Quant Biol; 2011; 76():129-37. PubMed ID: 21859674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation: a role for NR4A orphan nuclear receptors?
    McMorrow JP; Murphy EP
    Biochem Soc Trans; 2011 Apr; 39(2):688-93. PubMed ID: 21428963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARs and molecular mechanisms of transrepression.
    Ricote M; Glass CK
    Biochim Biophys Acta; 2007 Aug; 1771(8):926-35. PubMed ID: 17433773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver X receptor: a cardinal target for atherosclerosis and beyond.
    Parikh M; Patel K; Soni S; Gandhi T
    J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Okra polysaccharide improves metabolic disorders in high-fat diet-induced obese C57BL/6 mice.
    Fan S; Guo L; Zhang Y; Sun Q; Yang B; Huang C
    Mol Nutr Food Res; 2013 Nov; 57(11):2075-8. PubMed ID: 23894043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.
    Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR
    Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity.
    Motoshima K; Ishikawa M; Hashimoto Y; Sugita K
    Bioorg Med Chem; 2011 May; 19(10):3156-72. PubMed ID: 21514830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver X receptors bridge hepatic lipid metabolism and inflammation.
    Liu Y; Qiu DK; Ma X
    J Dig Dis; 2012 Feb; 13(2):69-74. PubMed ID: 22257474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear transcription factors and lipid homeostasis in liver.
    Chen YX; Huang AL; Ruan XZ
    Chin Med J (Engl); 2007 Dec; 120(24):2290-6. PubMed ID: 18167220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.